tag:blogger.com,1999:blog-7857054149675424609.post825373717619262516..comments2024-02-24T08:58:08.581+00:00Comments on RNAi Therapeutics: Is Dendrimer-siRNA Delivery Reaching Critical Mass?Dirk Hausseckerhttp://www.blogger.com/profile/18320439857875629714noreply@blogger.comBlogger3125tag:blogger.com,1999:blog-7857054149675424609.post-64944334327037942132013-07-16T18:10:07.335+00:002013-07-16T18:10:07.335+00:00I work for an immigration attorney who has a clien...I work for an immigration attorney who has a client with vast experience working with phosphorus dendrimers. His client would like to continue her research with phosphorus dendrimers in the United States, and we feel the United States could greatly benefit from her expertise. We are looking for an expert who would be willing to review our client’s publications and the like and, if appropriate, Anonymoushttps://www.blogger.com/profile/09080006339781595198noreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-21613189762542011532009-11-04T09:09:43.424+00:002009-11-04T09:09:43.424+00:00Hi Nick- No I haven't seen any follow-up fro t...Hi Nick- No I haven't seen any follow-up fro that paper, except a recent comment by Roche that for now they will be using SNALP for first clinical programs while developing second-generation DPCs for use in the clinic later on.<br /><br />After the Mirus acquisition by Roche, public access to that line of research will probably become more difficult. The best places to get some insights Dirk Hausseckerhttps://www.blogger.com/profile/18320439857875629714noreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-42894514632181795082009-11-02T18:22:54.856+00:002009-11-02T18:22:54.856+00:00Thanks Dirk. I really enjoy reading your blog. By ...Thanks Dirk. I really enjoy reading your blog. By the way, what ever happened to Mirus' DPC technology? I haven't seen any followup after the Rozema et al. PNAS paper. Thanks.Nicknoreply@blogger.com